tradingkey.logo

Revvity Inc

RVTY
101.590USD
+2.070+2.08%
收盤 02/06, 16:00美東報價延遲15分鐘
11.52B總市值
49.11本益比TTM

Revvity Inc

101.590
+2.070+2.08%

關於 Revvity Inc 公司

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.

Revvity Inc簡介

公司代碼RVTY
公司名稱Revvity Inc
上市日期Aug 12, 2101
CEOSingh (Prahlad R)
員工數量11000
證券類型Ordinary Share
年結日Aug 12
公司地址77 4Th Avenue
城市WALTHAM
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編02451
電話17816636900
網址https://www.revvity.com/
公司代碼RVTY
上市日期Aug 12, 2101
CEOSingh (Prahlad R)

Revvity Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.21K
+23375.00%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+2840.00%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
43.25K
+5558.00%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
29.36K
+6554.00%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+2412.00%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
19.15K
+4865.00%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
14.53K
+4089.00%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+2412.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+2412.00%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+2412.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
120.21K
+23375.00%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+2840.00%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
43.25K
+5558.00%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
29.36K
+6554.00%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+2412.00%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
19.15K
+4865.00%

收入明細

FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
Americas
509.67M
0.00%
Europe
391.67M
0.00%
Asia
189.28M
0.00%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 1月16日 週五
更新時間: 1月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.58%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
其他
47.23%
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.58%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
其他
47.23%
股東類型
持股股東
佔比
Investment Advisor
69.02%
Investment Advisor/Hedge Fund
26.41%
Hedge Fund
2.80%
Pension Fund
1.70%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
0.74%
Individual Investor
0.34%
Family Office
0.05%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1177
117.55M
103.68%
-9.50M
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Investment Management, Inc.
22.50M
19.85%
-140.67K
-0.62%
Sep 30, 2025
The Vanguard Group, Inc.
13.47M
11.88%
-564.06K
-4.02%
Sep 30, 2025
EdgePoint Investment Group Inc.
8.57M
7.56%
+1.78M
+26.28%
Sep 30, 2025
T. Rowe Price Associates, Inc.
8.00M
7.05%
+196.30K
+2.52%
Sep 30, 2025
Janus Henderson Investors
7.63M
6.73%
+405.54K
+5.62%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
6.04M
5.33%
+229.56K
+3.95%
Sep 30, 2025
State Street Investment Management (US)
4.95M
4.36%
-71.58K
-1.43%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.96M
2.61%
-16.67K
-0.56%
Sep 30, 2025
Invesco Capital Management LLC
2.26M
1.99%
+317.90K
+16.41%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.13M
1.88%
+596.44K
+38.99%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
查看更多
First Trust Indxx Medical Devices ETF
佔比2.12%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.85%
T Rowe Price Capital Appreciation Equity ETF
佔比1.36%
Simplify Health Care ETF
佔比1.29%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.16%
First Trust Health Care Alphadex Fund
佔比0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
佔比0.84%
VanEck Morningstar SMID Moat ETF
佔比0.64%
Neuberger Berman Small-Mid Cap ETF
佔比0.56%
NYLI Candriam US Mid Cap Equity ETF
佔比0.5%

分紅派息

近5年累計派現 137.14M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
查看更多

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI